619
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Development of lipid nanoparticles for transdermal loteprednol etabonate delivery

ORCID Icon, , , &
Pages 327-340 | Received 20 Jan 2022, Accepted 16 May 2022, Published online: 01 Jun 2022

References

  • Aburahma, M.H. and Badr-Eldin, S.M., 2014. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert opinion on drug delivery, 11 (12), 1865–1883.
  • Afanas’ev, N.I., Selyanina, S.B., and Selivanova, N.V., 2008. Stabilization of the oleic acid-water emulsion with various kraft lignins. Russian journal of applied chemistry, 81 (10), 1851–1855.
  • Alberth, M., et al., 1991. Lipophilicity, solubility and permeability of loteprednol etabonate: a novel, soft anti-inflammatory steroid. Journal of biopharmaceutical statistics, 2 (2), 115–125.
  • Almeida, E.D.P., et al., 2018. Skin permeation, biocompatibility and antitumor effect of chloroaluminum phthalocyanine associated to oleic acid in lipid nanoparticles. Photodiagnosis and photodynamic therapy, 24, 262–273.
  • Alsaqr, A., Rasoully, M., and Musteata, F.M., 2015. Investigating transdermal delivery of vitamin D3. AAPS PharmSciTech, 16 (4), 963–972.
  • Amon, M. and Busin, M., 2012. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. International ophthalmology, 32 (5), 507–517.
  • Attama, A.A., Momoh, M.A., and Builders, P.F., 2012. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. Recent advances in novel drug carrier systems, 5, 107–140.
  • Bhalekar, M., Upadhaya, P., and Madgulkar, A., 2017. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Applied nanoscience, 7 (1–2), 47–57.
  • Chen, G., et al., 2008. In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window. Nan fang yi ke da xue xue bao, 28 (6), 1022–1024.
  • Comstock, T.L. and Sheppard, J.D., 2018. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid. Expert opinion on pharmacotherapy, 19 (4), 337–353.
  • Das, A. and Panda, S., 2017. Use of topical corticosteroids in dermatology: an evidence-based approach. Indian journal of dermatology, 62 (3), 237–250.
  • De Oliveira, E.G., et al., 2019. Tailoring structural properties of spray-dried methotrexate-loaded poly (lactic acid)/poloxamer microparticle blends. Journal of materials science, 30 (1), 12.
  • Elmowafy, M., et al., 2018. Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation. International journal of pharmaceutics, 550 (1–2), 359–371.
  • Fong, R., et al., 2019. Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two phase III clinical studies. Clinical ophthalmology, 13, 1427–1438.
  • Fukushima, S., Takahashi, M., and Yamaguchi, M., 1976. Effect of cetostearyl alcohol on stabilization of oil-in-water emulsion: I. Difference in the effect by mixing cetyl alcohol with stearyl alcohol. Journal of colloid and interface science, 57 (2), 201–206.
  • Ghadiri, M., et al., 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. International journal of pharmaceutics, 424 (1–2), 128–137.
  • Goldstein, B.G., et al., 2021. Topical corticosteroids: use and adverse effects. In: R.P. Dellavalle and M.L. Levy, eds. Topical corticosteroids.
  • Gupta, V. and Trivedi, P., 2015. Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies. Artificial cells, nanomedicine, and biotechnology, 43 (6), 373–382.
  • Han, Y. and Segall, A., 2015. A validated specific stability-indicating RP-HPLC assay method for the determination of loteprednol etabonate in eye drops. Journal of chromatographic science, 53 (5), 761–766.
  • Houston, D.M.J., et al., 2017. Anti-inflammatory activity of Punica granatum L. (Pomegranate) rind extracts applied topically to ex vivo skin. European journal of pharmaceutics and biopharmaceutics, 112, 30–37.
  • International Conference on Harmonization. 2005. Validation of analytical procedures: text and methodology, vol 11. Geneva, Switzerland: ICH.
  • Jensen, L.B., Petersson, K., and Nielsen, H.M., 2011. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. European journal of pharmaceutics and biopharmaceutics, 79 (1), 68–75.
  • Jia, L., et al., 2010. Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug delivery, 17 (1), 11–18.
  • Kahraman, E., et al., 2018. The combination of nanomicelles with terpenes for enhancement of skin drug delivery. International journal of pharmaceutics, 551 (1–2), 133–140.
  • Kar, M., et al., 2019. Current developments in excipient science: implication of quantitative selection of each excipient in product development. In: R.K. Tekade, ed. Basic fundamentals of drug delivery. Cambridge, MA: Academic Press, 29–83.
  • Khames, A., et al., 2019. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. International journal of nanomedicine, 14, 2515–2531.
  • Khandelmai, N.P., Bhide, P., and Nachinolkar, R., 2019. Formulation and evaluation of solubility enhanced in situ gelling eye drops of loteprednol etabonate. Asian journal of pharmaceutical and clinical research, 12 (12), 209–216.
  • Korting, H.C. and Schäfer-Korting, M., 2010. Carriers in the topical treatment of skin disease. Drug delivery, 197, 435–468.
  • LGC GmbH. 2017. Certificate of analysis reference standard loteprednol etabonate (TGZ II. D-14943). Luckenwalde, Germany: LGC GmbH.
  • Ng, S., et al., 2010. A comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using franz diffusion cells. Pharmaceutics, 2 (2), 209–223.
  • Nihant, N., et al., 1994. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharmaceutical research, 11 (10), 1479–1484.
  • Noble, S. and Goa, K.L., 1998. Loteprednol etabonate: clinical potential in the management of ocular inflammation. BioDrugs, 10 (4), 329–339.
  • Olatunji, O., et al., 2013. Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. Journal of pharmaceutical sciences, 102 (4), 1209–1221.
  • Özdemir, S., et al., 2018. Eplerenone nanoemulsions for treatment of hypertension. Part I: experimental design for optimization of formulations and physical characterization. Journal of drug delivery science and technology, 45, 357–366.
  • Özdemir, S., 2016. Aldosteron antagonisti eplerenonun yeni formülasyonlarının geliştirilmesi üzerine çalışmalar. İstanbul, Turkey: İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü.
  • Padhye, S.G. and Nagarsenker, M.S., 2013. Simvastatin solid lipid nanoparticles for oral delivery: formulation development and in vivo evaluation. Indian journal of pharmaceutical sciences, 75 (5), 591–598.
  • Parra, A., et al., 2016. Ex vivo permeation of carprofen from nanoparticles: a comprehensive study through human, porcine and bovine skin as anti-inflammatory agent. International journal of pharmaceutics, 501 (1–2), 10–17.
  • Patra, J.K., et al., 2018. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology, 16 (1), 1–33.
  • Pepe, D., et al., 2016. Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel. International journal of nanomedicine, 11, 2009–2019.
  • Ramadon, D., et al., 2022. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug delivery and translational research, 12 (4), 734–758.
  • Rathi, S.K. and D’Souza, P., 2012. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian journal of dermatology, 57 (4), 251–259.
  • Sahoo, S., et al., 2020. Formulation and evaluation of sustained release in situ gel of loteprednol etabonate by using 3 2 full factorial design. Aegaeum journal, 8 (4), 566.
  • Schmid-Wendtner, M.H. and Korting, H.C., 2006. The pH of the skin surface and its impact on the barrier function. Skin pharmacology and physiology, 19 (6), 296–302.
  • Shimojo, A.A.M., et al., 2019. Evaluation of the influence of process parameters on the properties of resveratrol-loaded NLC using 22 full factorial design. Antioxidants, 8 (8), 272.
  • Siekmann, B. and Westesen, K., 1994. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids and surfaces B: Biointerfaces, 3 (3), 159–175.
  • Souto, E.B., Almeida, A.J., and Müller, R.H., 2007. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. Journal of biomedical nanotechnology, 3 (4), 317–331.
  • Tatke, A., et al., 2018. In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies. Nanomaterials, 9 (1), 33.
  • Uchechi, O., Ogbonna, J.D., and Attama, A.A., 2014. Nanoparticles for dermal and transdermal drug delivery. Application of nanotechnology in drug delivery, 4, 193–227.
  • Üner, M., Karaman, E., and Aydoğmuş, Z., 2014a. Solid lipid nanoparticles and nanostructured lipid carriers of loratadine for topical application: physicochemical stability and drug penetration through rat skin. Tropical journal of pharmaceutical research, 13 (5), 653.
  • Üner, M., et al., 2014b. Solid lipid nanoparticles and nanostructured lipid carriers of celecoxib for topical application – preparation. characterization and drug penetration through rat skin. Current nanoscience, 10 (4), 532–542.
  • Üner, M., Yener, G., and Ergüven, M., 2019. Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia. Materials science and engineering: C, 103, 109874.
  • Vieira, S., et al., 2020. Sucupira oil-loaded nanostructured lipid carriers (NLC): lipid screening, factorial design, release profile, and cytotoxicity. Molecules, 25 (3), 685.
  • Wissing, S.A., Lippacher, A., and Müller, R.H., 2001. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). Journal of cosmetic science, 52 (5), 313–324.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.